NEUROBIOTEX, INC.

Medtech · Private

Portable hand-held instrument for diagnosing zinc deficiency via fingernail analysis using X-ray fluorescence

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$1.3M
Federal grants
$1.3M
3 awards · 2017–2018
Rank in peer group#337 of 477
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20172018FEDERAL ↑EQUITY ↓Cumulative $1.3M$917K$7K$415K
20172018FEDERAL ↑EQUITY ↓Cumulative $1.3M$917K$7K$415K

Latest events

  • Federal grantHealth and Human S · Phase II · Portable Instrument for Assessing Zinc Deficiency in Children and the Elderly$415K
  • Federal grantHealth and Human S · Phase II · Portable Instrument for Assessing Zinc Deficiency in Children and the Elderly$7K
  • Federal grantHealth and Human S · Phase II · Portable Instrument for Assessing Zinc Deficiency in Children and the Elderly$917K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Linked publications#11 · top 2%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 3
  • PendingZintrodes, Multitrodes And Uses ThereofUSPTOApplication PCTUS2004028137
  • PendingZinc-based Screening Test And Kit For Early Diagnosis Of Prostate CancerUSPTOApplication PCTUS2004012253
  • PendingReduction Of Zinc-induced Neurotoxic Injury By Blockade Of Nitric Oxide SynthesisUSPTOApplication PCTUS2004008619

Recent research by its founders

  • Single hair analysis by X-ray fluorescence spectrometry detects small changes in dietary zinc intake: A nested randomized controlled trial202311 cites
  • Radiographic presentation of artifactual dyed hair on lateral cephalograms, chemical processing, and forensic application: Novel case report20225 cites
  • Quality Control of Solder Paste Utilizing Electrochemical Impedance Spectroscopy20200 cites

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .